TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-14.07%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.34B
AUM Growth
+$2.34B
(-15%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
40.93%
Holding
221
New
9
Increased
52
Reduced
52
Closed
18
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$14.9M |
| 2 |
Medtronic
MDT
|
$12.9M |
| 3 |
UnitedHealth
UNH
|
$7.69M |
| 4 |
Pfizer
PFE
|
$7.1M |
| 5 |
Merck
MRK
|
$7.1M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$17M |
| 2 |
AstraZeneca
AZN
|
$11M |
| 3 |
Idexx Laboratories
IDXX
|
$9.46M |
| 4 |
Omega Healthcare
OHI
|
$7.02M |
| 5 |
Viatris
VTRS
|
$6.94M |
Sector Composition
| 1 | Healthcare | 94.39% |
| 2 | Real Estate | 2.48% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
76
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $6.17M | 0.26% | 63,345 +19,747 | +45% | +$1.92M |
|
|
IMMU
77
DELISTED
Immunomedics Inc
IMMU
| $6.16M | 0.26% | 431,527 +334,157 | +343% | +$4.77M |
|
78
Ventas
VTR
$30.9B
| $5.77M | 0.25% | 98,496 | – | – |
|
|
PVLA
79
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $5.55M | 0.24% | 2,087,380 | – | – |
|
80
Quest Diagnostics
DGX
$20.3B
| $5.54M | 0.24% | 66,500 +27,500 | +71% | +$2.29M |
|
|
ENDP
81
DELISTED
Endo International plc
ENDP
| $5.24M | 0.22% | 717,274 -301,774 | -30% | -$2.2M |
|
|
ARRY
82
DELISTED
Array Biopharma Inc
ARRY
| $5.19M | 0.22% | 364,166 | – | – |
|
83
Merus
MRUS
$4.98B
| $5.15M | 0.22% | 367,671 -46,444 | -11% | -$650K |
|
84
Steris
STE
$24.1B
| $5.13M | 0.22% | 48,003 +12,800 | +36% | +$1.37M |
|
85
CRISPR Therapeutics
CRSP
$4.71B
| $5.1M | 0.22% | 178,348 | – | – |
|
86
Dentsply Sirona
XRAY
$2.85B
| $4.68M | 0.2% | 125,625 +68,025 | +118% | +$2.53M |
|
87
IQVIA
IQV
$32.4B
| $4.54M | 0.19% | 39,100 +22,300 | +133% | +$2.59M |
|
88
United Therapeutics
UTHR
$13.8B
| $4.49M | 0.19% | 41,261 | – | – |
|
89
Ionis Pharmaceuticals
IONS
$6.79B
| $4.48M | 0.19% | 82,838 | – | – |
|
90
Alkermes
ALKS
$4.78B
| $4.46M | 0.19% | 151,283 -19,759 | -12% | -$583K |
|
91
Acadia Healthcare
ACHC
$2.12B
| $4.45M | 0.19% | 173,155 -99,245 | -36% | -$2.55M |
|
|
DHC
92
Diversified Healthcare Trust
DHC
$920M
| $4.42M | 0.19% | 377,220 -269,334 | -42% | -$3.16M |
|
93
AnaptysBio
ANAB
$569M
| $4.2M | 0.18% | 65,845 +19,935 | +43% | +$1.27M |
|
|
ZGNX
94
DELISTED
Zogenix, Inc.
ZGNX
| $4.05M | 0.17% | 111,025 +44,843 | +68% | +$1.63M |
|
|
ABMD
95
DELISTED
Abiomed Inc
ABMD
| $4.01M | 0.17% | 12,350 +8,600 | +229% | +$2.8M |
|
|
CLLS
96
Cellectis
CLLS
$258M
| $3.94M | 0.17% | 236,530 -42,458 | -15% | -$707K |
|
|
GBT
97
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.86M | 0.17% | 93,924 -38,346 | -29% | -$1.57M |
|
98
Labcorp
LH
$23.1B
| $3.68M | 0.16% | 29,100 +16,900 | +139% | +$2.14M |
|
|
WMGI
99
DELISTED
Wright Medical Group Inc
WMGI
| $3.63M | 0.16% | 133,391 -133,390 | -50% | -$3.63M |
|
100
Ligand Pharmaceuticals
LGND
$3.15B
| $3.59M | 0.15% | 26,450 +17,510 | +196% | +$2.38M |
|